Literature DB >> 17015254

Polyphenols from green tea and pomegranate for prevention of prostate cancer.

Vaqar M Adhami1, Hasan Mukhtar.   

Abstract

Prostate cancer (PCa) is the most common non-cutaneous cancer diagnosed in North America with similar trends in many Western countries. Geographic, epidemiological and laboratory studies suggest a role for dietary constituents in the etiology as well as prevention of PCa. The rising incidence of PCa in several countries appears to be coincidental with adoption of western lifestyle. Increase in the incidence of PCa has also been found in Asian populations migrating to the west. These facts give numerous leads to explore testable PCa prevention strategies. There is growing evidence in support of use of dietary ingredients in prevention and treatment of PCa. While substantial data exists in favor of use of polyphenols from tea as PCa chemopreventive agent, interest in anti-cancer properties of polyphenols from pomegranate has recently emerged. This review summarizes current literature on the effects of polyphenols from green tea and pomegranate against PCa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015254     DOI: 10.1080/10715760600796498

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  13 in total

Review 1.  Commentary: bioavailability of flavonoids and polyphenols: call to arms.

Authors:  Ming Hu
Journal:  Mol Pharm       Date:  2007 Nov-Dec       Impact factor: 4.939

2.  The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis.

Authors:  Xiawei Fei; Yanting Shen; Xiaogong Li; Hongqian Guo
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

4.  Evaluation of antioxidant and antiradical properties of Pomegranate (Punica granatum L.) seed and defatted seed extracts.

Authors:  Shadi Basiri
Journal:  J Food Sci Technol       Date:  2013-07-11       Impact factor: 2.701

Review 5.  Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.

Authors:  Naghma Khan; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells.

Authors:  Naghma Khan; Farrukh Afaq; Deeba N Syed; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2008-03-20       Impact factor: 4.944

7.  Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.

Authors:  Moammir H Aziz; Nancy E Dreckschmidt; Ajit K Verma
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

8.  Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms.

Authors:  Hilal Zaid; Michael Silbermann; Eran Ben-Arye; Bashar Saad
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-22       Impact factor: 2.629

9.  Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2008-06-13       Impact factor: 4.981

10.  Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.

Authors:  Meichun Hu; Shihong Peng; Yundong He; Min Qin; Xiaonan Cong; Yajing Xing; Mingyao Liu; Zhengfang Yi
Journal:  Oncotarget       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.